BR9806871A - Processo para a preparação de omeprazol, formulação farmacêutica, e, omeprazol. - Google Patents

Processo para a preparação de omeprazol, formulação farmacêutica, e, omeprazol.

Info

Publication number
BR9806871A
BR9806871A BR9806871-7A BR9806871A BR9806871A BR 9806871 A BR9806871 A BR 9806871A BR 9806871 A BR9806871 A BR 9806871A BR 9806871 A BR9806871 A BR 9806871A
Authority
BR
Brazil
Prior art keywords
omeprazole
preparation
methoxy
pharmaceutical formulation
benzimidazole
Prior art date
Application number
BR9806871-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Hanna Cotton
Magnus Larsson
Anders Mattson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9806871A publication Critical patent/BR9806871A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
BR9806871-7A 1997-11-14 1998-11-03 Processo para a preparação de omeprazol, formulação farmacêutica, e, omeprazol. BR9806871A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704183A SE9704183D0 (sv) 1997-11-14 1997-11-14 New process
PCT/SE1998/001984 WO1999025711A1 (en) 1997-11-14 1998-11-03 New process

Publications (1)

Publication Number Publication Date
BR9806871A true BR9806871A (pt) 2000-04-18

Family

ID=20408989

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806871-7A BR9806871A (pt) 1997-11-14 1998-11-03 Processo para a preparação de omeprazol, formulação farmacêutica, e, omeprazol.

Country Status (35)

Country Link
US (1) US6303788B1 (Direct)
EP (1) EP0964859A1 (Direct)
JP (1) JP2001508466A (Direct)
KR (1) KR20000070069A (Direct)
CN (1) CN1145624C (Direct)
AR (1) AR013740A1 (Direct)
AU (1) AU750743B2 (Direct)
BR (1) BR9806871A (Direct)
CA (1) CA2276753A1 (Direct)
DE (1) DE964859T1 (Direct)
DZ (1) DZ2641A1 (Direct)
EE (1) EE04154B1 (Direct)
ES (1) ES2138950T1 (Direct)
GR (1) GR990300046T1 (Direct)
HR (1) HRP990218A2 (Direct)
HU (1) HUP0003737A3 (Direct)
ID (1) ID21999A (Direct)
IL (1) IL130647A0 (Direct)
IN (1) IN190801B (Direct)
IS (1) IS5106A (Direct)
MA (1) MA26564A1 (Direct)
MY (1) MY118199A (Direct)
NO (1) NO318197B1 (Direct)
NZ (1) NZ336447A (Direct)
PL (1) PL334701A1 (Direct)
RU (1) RU2211218C2 (Direct)
SE (1) SE9704183D0 (Direct)
SK (1) SK87299A3 (Direct)
TN (1) TNSN98202A1 (Direct)
TR (1) TR199901643T1 (Direct)
TW (1) TW588046B (Direct)
UA (1) UA68342C2 (Direct)
WO (1) WO1999025711A1 (Direct)
YU (1) YU31199A (Direct)
ZA (1) ZA989999B (Direct)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
IL142703A (en) 1998-11-10 2006-04-10 Astrazeneca Ab Crystalline form of omeprazole
UA72748C2 (en) 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
CN1876647A (zh) * 2001-02-02 2006-12-13 特瓦制药工业有限公司 苯并咪唑化合物产品
SE0203092D0 (en) 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ATE443051T1 (de) 2004-10-11 2009-10-15 Ranbaxy Lab Ltd Verfahren zur herstellung substituierter sulfoxide
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
CN1810803B (zh) * 2006-02-17 2010-11-17 中国科学院上海有机化学研究所 高对映体选择性制备(s)-奥美拉唑的方法
CN101538264A (zh) * 2008-03-19 2009-09-23 中国科学院成都有机化学有限公司 手性亚砜类化合物的制备新方法
CN102603621B (zh) * 2012-02-07 2013-09-04 成都苑东药业有限公司 一种新型手性亚砜化合物和以该化合物制备埃索美拉唑钠的方法
CN106083819A (zh) * 2016-06-08 2016-11-09 扬子江药业集团有限公司 一种奥美拉唑的制备方法
ES2948511A1 (es) * 2021-09-08 2023-09-13 Fundacion Para La Investigacion Biomedica Del Hospital Univ De La Princesa Derivados de n-sulfonilureas y su uso terapeutico

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
SE9002043D0 (sv) 1990-06-07 1990-06-07 Astra Ab Improved method for synthesis
NZ244301A (en) 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider

Also Published As

Publication number Publication date
KR20000070069A (ko) 2000-11-25
CA2276753A1 (en) 1999-05-27
IS5106A (is) 1999-07-02
TNSN98202A1 (fr) 2005-03-15
NZ336447A (en) 2001-02-23
MA26564A1 (fr) 2004-12-20
AU750743B2 (en) 2002-07-25
SK87299A3 (en) 2000-02-14
SE9704183D0 (sv) 1997-11-14
IN190801B (Direct) 2003-08-23
MY118199A (en) 2004-09-30
HRP990218A2 (en) 2000-08-31
YU31199A (sh) 2002-06-19
RU2211218C2 (ru) 2003-08-27
IL130647A0 (en) 2000-06-01
WO1999025711A1 (en) 1999-05-27
ID21999A (id) 1999-08-19
TR199901643T1 (xx) 2000-01-21
AU1058299A (en) 1999-06-07
NO318197B1 (no) 2005-02-14
EE04154B1 (et) 2003-10-15
TW588046B (en) 2004-05-21
CN1145624C (zh) 2004-04-14
HUP0003737A2 (hu) 2001-10-28
PL334701A1 (en) 2000-03-13
GR990300046T1 (en) 2000-07-31
EP0964859A1 (en) 1999-12-22
JP2001508466A (ja) 2001-06-26
AR013740A1 (es) 2001-01-10
HUP0003737A3 (en) 2002-01-28
ZA989999B (en) 1999-06-17
NO993298D0 (no) 1999-07-02
US6303788B1 (en) 2001-10-16
CN1243512A (zh) 2000-02-02
NO993298L (no) 1999-07-02
EE9900391A (et) 2000-04-17
ES2138950T1 (es) 2000-02-01
DE964859T1 (de) 2000-05-04
DZ2641A1 (fr) 2003-03-15
UA68342C2 (en) 2004-08-16

Similar Documents

Publication Publication Date Title
AR013350A1 (es) Sal de sodio de omeprazol forma b, proceso para su preparacion, formulacion farmaceutica, y uso de dicha sal para la fabricacion de medicamentos.
AR013740A1 (es) Proceso para la preparacion de omeprazol, compuesto y formulacion farmaceutica del mismo
BR9915852A (pt) Conjugado de hapteno-portador para tratamento e prevenção do vìcio da nicotina
BR0209103A (pt) Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica
BR9809484A (pt) Formulação farmacêutica oral revestida entérica, processo para a manufatura da mesma, uso de uma qualidade de hidroxipropil metilcelulose (hpmc) de baixa viscosidade, e, processo para o tratamento de doenças gastrointestinais em mamìferos, incluindo o homem.
ATE94063T1 (de) Verwendung von omeprazol als antimikrobielles mittel.
AR010361A1 (es) "S-OMEPRAZOL [ENANTIoMERO S DE 5-METOXI-2-[[(4--METOXI-3,5-DIMETIL-2-PIRIDINIL)-METIL]SULFINIL]-1H-BENCIMIDAZOL], EN UNA FORMA NEUTRA NO SALINA, PROCESO PARA SU PREPARACION, COMPOSICION FARMACEUTICA, Y SU USO PARA LA MANUFACTURA DE MEDICAMENTOS"
ES2110377T1 (es) Formulacion galenica de fenofibrato y aplicacion de la misma.
BR0108584A (pt) Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva
DK0553191T3 (da) Pyridin- og pyridin-N-oxidderivater af diarylmethylpiperidiner eller -piperaziner, præparater og an vendelse deraf
AR018197A1 (es) Compuestos de piperidina, un procedimiento para su preparacion, una composicion y uso del mismo para la preparacion de un medicamento
TR200102138T2 (tr) (S)-Omeprazolün potasyum tuzu.
DE59104271D1 (de) Lösungsmittelfreie, oral zu verabreichende pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung und verfahren zu deren herstellung.
LV10268A (lv) Terapeitiski aktivs benzimidazols un ta iegusanas panemiens
ES2153835T3 (es) Formulaciones farmaceuticas estables a base de nicorandil.
BR0104345A (pt) Tratamento combinado para a depressão e ansiedade
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
DE3867042D1 (de) Pharmazeutische praeparate.
DE60010230D1 (de) Pharmazeutische zusammensetzung von hydrophob modifizierten hedgehog-proteinen und deren verwendung
CY1107421T1 (el) Τρυγικα αλατα παραγωγου θειαζολιδινοδιονης
BR0112984A (pt) Sais tartarato de derivado de tiazolidinodiona
IT1271434B (it) Composizione farmaceutica avente attivita' antiasmatica

Legal Events

Date Code Title Description
TC Change of name
B09B Patent application refused [chapter 9.2 patent gazette]